Abeona Therapeutics (ABEO) Announces Proposed Common Share Offering
Get Alerts ABEO Hot Sheet
Join SI Premium – FREE
Abeona Therapeutics Inc. (NASDAQ: ABEO) today announced that it intends to offer and sell shares of its common stock, and pre-funded warrants in lieu of common stock, in an underwritten public offering pursuant to an existing shelf registration statement. All of the securities in the offering are to be sold by Abeona. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.
An existing holder of the Company’s common stock, Great Point Partners (“GPP”), has indicated its intention to purchase up to $33 million in the offering, including pre-funded warrants in lieu of common stock, subject to allocation by the underwriter and market and other conditions, including the ability to nominate two directors, including a new Executive Chairman, to Abeona’s Board of Directors. GPP has indicated that it expects such director nominees would be industry professionals not affiliated with such holder. As a result, Steven H. Rouhandeh would step down as Executive Chairman and would retain a seat on the Board, while Mark J. Alvino and Richard Van Duyne would exit the Board. These changes would be effective upon the Board’s qualification and election of GPP’s nominees.
Jefferies LLC is acting as sole book-running manager and underwriter for the offering. Abeona intends to grant the underwriter a 30-day option to purchase additional shares of its common stock in an amount up to 15% of the securities sold in the offering, on the same terms and conditions.
Abeona intends to use the net proceeds of the offering to fund continued clinical development of pipeline products, as well as for working capital and corporate purposes.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- QNB Corp. overallotment option adds 160,714 shares at $42 each
- Jefferies: 38% of Australian companies beat estimates this season
- Aveanna selling stockholders launch 15M share secondary offering
Create E-mail Alert Related Categories
Corporate News, Equity OfferingsRelated Entities
Jefferies & Co, S3, FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share